The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: Relationship to tumour pathology

European Journal of Cancer

Volumn 39, Issue 7, 2003, Pages 981-988

  Baker, E A ^a   Leaper, D J ^a  

^a UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

Author keywords

Colorectal cancer; Matrix metalloproteinases; Plasminogen activator inhibitors; Plasminogen activators; Tissue inhibitors of metalloproteinases

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; HYDROLYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANK SUM TEST; TISSUE LEVEL; TUMOR DIFFERENTIATION; VASCULAR DISEASE; ZYMOGRAPHY;

EID: 0037403588     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00065-0     Document Type: Article

References (30)

1. Raza S.L., Cornelius L.A. Matrix metalloproteinases. pro and anti-angiogenic activities J. Invest. Dermatol. Symposium Proceedings. 5:2000;47-54.
2. Ennis B.W., Matrisian L.M. Matrix degrading metalloproteinases. J. Neurooncol. 18:1994;105-198.
3. Ray J.M., Stetler-Stevenson W.G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7:1995;2062-2072.
4. Berger D.H. Plasmin/plasminogen system in colorectal cancer. World. J. Surg. 26:2002;767-771.
5. Gandolfo G.M., Conti L., Vercillo M. Fibrinolysis components in breast cancer and colorectal carcinoma. Anticancer Res. 16:1996;2155-2160.
6. Sardinha T.C., Nogueras J.J., Xiong H., Weiss E.G., Wexner S.D., Abramson S. Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer. Dis. Colon. Rectum. 43:2000;389-395.
7. Garbett E.A., Reed M.W.R., Brown N.J. Proteolysis in colorectal cancer. J. Clin. Pathol.: Mol. Pathol. 52:1999;140-145.
8. Zeng Z.S., Guillem J.G. Distinct patterns of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase-1 mRNA expression in colorectal cancer and liver metastases. Br. J. Cancer. 72:1995;575-582.
9. Sier C.F.M., Verspaget H.V., Griffioen G.et al. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implication of urokinase in colorectal carcinogenesis. Gastroenterology. 101:1991;1522-1558.
10. Sunami E., Tsuno N., Osada T.et al. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist. 5:2000;108-114.
11. Adachi Y., Yamamoto H., Itoh F., Hinoda Y., Okada Y., Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut. 45:1999;252-258.
12. Stephens R.W., Nielsen H.J., Thorlacius-Ussing O., Sorensen S., Dano K., Brunner N. Plasma urokinase receptor levels in patients with colorectal cancer. relationship to poor prognosis J. Natl. Cancer Inst. 91:1999;869-874.
13. Skelly M.M., Troy A., Duffy M.J.et al. Urokinase-type plasminogen activator in colorectal cancer. relationship with clinicopathological features and patient outcome Clin. Cancer Res. 3:1997;1837-1840.
14. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2:1996;461-462.
15. Kikuchi R., Noguchi T., Kubo N., Uchida Y. Immunohistochemical detection of membrane-type-1 matrix metalloproteinase in colorectal carcinoma. Br. J. Cancer. 83:2000;215-218.
16. Liabakk N.B., Talbot I., Smith R.A., Wilkinson K., Balkwill F. Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56:1996;190-196.
17. Saito K., Takeha S., Shiiba K.et al. Clinicopathologic significance of urokinase receptor and MMP-9 positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis. Int J Cancer. 86:2000;24-29.
18. Mukai M., Sadahiro S., Tokunaga N.et al. The expression of MMP-2 and TIMP-2 in patients with primary colorectal adenocarcinomas. correlation with liver metastasis Oncol. Rep. 6:1999;969-973.
19. Ohnishi S.T., Barr J.K. A simplified method of quantifying proteins using the biuret and phenol reagents. Anal. Biochem. 86:1978;193-200.
20. Heussen C., Dowdle E. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerised substrates. Anal. Biochem. 102:1980;196-202.
21. Baker E.A., Leaper D.J. Gelatinase activity in colorectal cancer. EJSO. 28:2002;24-29.
22. Knight C.G., Willenbrock F., Murphy G. A novel coumarin labelled peptide for sensitive continuous assays of matrix metalloproteinases. FEBS Lett. 296:1992;263-266.
23. Inuzuka K., Ogata Y., Nagase H., Shirouzu Significance of coexpression of urokinase-type plasminogen activator and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. J. Surg. Res. 93:2000;211-218.
24. Baker E.A., Bergin F.G., Leaper D.J. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br. J. Surg. 87:2000;1215-1221.
25. Baker E.A., Bergin F.G., Leaper D.J. Plasminogen activator system, vascular endothelial growth factor and colorectal cancer progression. J. Clin. Path.: Mol. Path. 53:2000;307-312.
26. Ganesh S., Sier C.F., Heerding M.M., Griffioen G., Lamers C.B., Verspaget H.W. Urokinase receptor and colorectal cancer survival [letter]. Lancet. 344:1994;401-402.
27. de Bruin P.A., Griffioen G., Verspaget H.W., Verheijen J.H., Lamers C.B. Plasminogen activator profiles in neoplastic tissues of the human colon. activity levels in normal mucosa, adenomatous polyps and adenocarcinomas Cancer Res. 47:1987;4654-4657.
28. Zeng Z.S., Cohen A.M., Zhang Z.F., Stetler-Stevenson W., Guillem J.G. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastasis. Clinical Cancer Res. 1:1995;889-906.
29. Yang J.L., Seetoo D.Q., Wang Y.et al. Urokinase-type plasminogen activator and its receptor in colorectal cancer. independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets Int. J. Cancer. 89:2000;431-439.
30. Herszenyi L., Plebani M., Carraro P.et al. The role of cysteine and serine proteases in colorectal carcinoma. Cancer. 86:1999;1135-1142.